To include your compound in the COVID-19 Resource Center, submit it here.

Flurry of management moves on eve of JPM

More than 30 biopharma companies announced executive changes to kick off the New Year, including Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and Immunocore Ltd. (Abingdon, U.K.), both of which brought on former AstraZeneca plc (LSE:AZN; NYSE:AZN) executives (see "AZ's Mallon to Lead Ironwood; Hecht to Helm Spinout"; "Immunocore Taps MedImmune's Jallal as CEO").

Here's BioCentury Extra's roundup in alphabetical order:

Cancer company Adastra Pharmaceuticals Inc. (Princeton, N.J.), which changed its name from Tragara Pharmaceuticals Inc. on Jan. 3, hired Scott Megaffin as CEO and a director. Megaffin replaces Tom Estok, who remains a director. Megaffin was president of Churchill Pharmaceuticals LLC (King of Prussia, Pa.).

Metabolic disease company Allena Pharmaceuticals Inc. (NASDAQ:ALNA) will promote President and COO Louis Brenner to CEO, effective Feb. 1. He succeeds co-founder and CEO Alexey Margolin,

Read the full 1265 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE